Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
1.550
+0.010 (0.65%)
Feb 11, 2026, 1:54 PM EST - Market open
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $7.36 million as of February 11, 2026. Its market cap has increased by 269.36% in one year.
Market Cap
7.36M
Enterprise Value
-5.40M
1-Year Change
269.36%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $7.36M, a decrease of -91.87%. That is a compound annual growth rate of -38.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 7.31M | 54.30% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 8.94M |
| XTL Biopharmaceuticals | 8.83M |
| CalciMedica | 8.65M |
| BioVie | 8.52M |
| TransCode Therapeutics | 8.17M |
| Kiora Pharmaceuticals | 7.89M |
| Theriva Biologics | 7.85M |
| Quince Therapeutics | 7.75M |